Related Experiment Videos
[Hyperpyrexia and rhabdomyolysis after ecstasy (MDMA) intoxication]
1Klinik für Anästhesiologie, Universitätsklinikum der RWTH Aachen. okunitz@ukaachen.de
Der Anaesthesist
|July 2, 2003
Summary
This case study details a severe 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) overdose. Effective treatment involved dantrolene for hyperpyrexia and supportive care for multi-organ failure.
Area of Science:
- Toxicology
- Emergency Medicine
- Pharmacology
Background:
- 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) abuse is increasing, leading to severe complications.
- Reported severe complications include hyperpyrexia, rhabdomyolysis, disseminated intravascular coagulation (DIC), and organ failure.
Observation:
- A 21-year-old male presented with a suicidal overdose of MDMA.
- He developed severe hyperpyrexia (>43°C), rhabdomyolysis (myoglobin 88,000 µg/l), DIC, and early renal and liver failure.
Findings:
- Intravenous dantrolene (140 mg) and cooling effectively treated hyperpyrexia.
- Aggressive intravenous fluid therapy (5 L/day) supported renal function, increasing elimination of myoglobin, urea, and creatinine, avoiding hemodialysis.
- Disseminated intravascular coagulation (DIC) was managed with antithrombin III, fresh frozen plasma, prothrombin complex concentrates, and aprotinin.
Implications:
- This case highlights the potential severity of MDMA overdose and the effectiveness of specific treatments.
- Prompt recognition and management of hyperpyrexia, rhabdomyolysis, DIC, and organ dysfunction are crucial for patient survival.
- Aggressive supportive care, including dantrolene and fluid management, can prevent the need for intensive interventions like hemodialysis.